{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T20:32:01Z","timestamp":1769805121484,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"DOI":"10.7759\/cureus.102615","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:31:21Z","timestamp":1769765481000},"source":"Crossref","is-referenced-by-count":0,"title":["Antibiotic Consumption and Gram-Negative Resistance Dynamics in the ICU: A Five-Year Autoregressive Integrated Moving Average (ARIMA) Analysis"],"prefix":"10.7759","author":[{"given":"Lejla","family":"Rakovac Tupkovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nijaz","family":"Tihic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmina","family":"Smajic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedim","family":"Osmanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirela","family":"Basic Denjagic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Predrag","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emir","family":"Becirovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minela","family":"Becirovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2013.00047","article-title":"The multifaceted roles of antibiotics and antibiotic resistance in nature","volume":"4","author":"Sengupta S","year":"2013","unstructured":"Sengupta S, Chattopadhyay MK, Grossart HP. The multifaceted roles of antibiotics and antibiotic resistance in nature. Front Microbiol. 2013, 4:47. 10.3389\/fmicb.2013.00047","journal-title":"Front Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101362","article-title":"Antimicrobial resistance and its drivers: a review","volume":"11","author":"Irfan M","year":"2022","unstructured":"Irfan M, Almotiri A, AlZeyadi ZA. Antimicrobial resistance and its drivers: a review. Antibiotics (Basel). 2022, 11:1362. 10.3390\/antibiotics11101362","journal-title":"Antibiotics (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.46.2400317","article-title":"Measuring hospital antibiotic consumption in EU\/EEA countries: comparison of different metrics, 2017 to 2021","volume":"29","author":"Rubini\u0107 I","year":"2024","unstructured":"Rubini\u0107 I, Leung VH, H\u00f6gberg LD, Monnet DL, Vlahovi\u0107-Pal\u010devski V. Measuring hospital antibiotic consumption in EU\/EEA countries: comparison of different metrics, 2017 to 2021. Euro Surveill. 2024, 29:10.2807\/1560-7917.ES.2024.29.46.2400317","journal-title":"Euro Surveill"},{"key":"ref4","article-title":"World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report","year":"2021","unstructured":"Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report. World Health Organization, Geneva, Switzerland; 2021. https.\/\/iris.who.int\/server\/api\/core\/bitstreams\/fff09e4b-fdec-444e-9d40-340b70c8a8a4\/content."},{"key":"ref5","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU\/EEA (EARS-Net) - annual epidemiological report for 2024. (2024). Accessed: January 28, 2026: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-eueea-ears-net-annual-epidemiological-report...."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2021.26.46.2001537","article-title":"Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018","volume":"26","author":"Barnsteiner S","year":"2021","unstructured":"Barnsteiner S, Baty F, Albrich WC, et al.. Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018. Euro Surveill. 2021, 26:2001537. 10.2807\/1560-7917.ES.2021.26.46.2001537","journal-title":"Euro Surveill"},{"key":"ref7","unstructured":"World Health Organization. The ATC\/DDD methodology. (2026). Accessed: January, 2026: https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/methodology."},{"key":"ref8","article-title":"","year":"2018","unstructured":"CLSI M100. Performance Standards for Antimicrobial Susceptibility Testing, 28th Ed. Clinical and Laboratory Standards Institute, Wayne, PA; 2018. https:\/\/www.calameo.com\/read\/007001748ccef4b9fdfe5."},{"key":"ref9","unstructured":"EUCAST. Clinical breakpoint tables. (2026). Accessed: 2026: https:\/\/www.eucast.org\/bacteria\/clinical-breakpoints-and-interpretation\/clinical-breakpoint-tables\/."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2017.0858","article-title":"Surveillance of antibiotic use and resistance in intensive care units (SARI)","volume":"114","author":"Remschmidt C","year":"2017","unstructured":"Remschmidt C, Schneider S, Meyer E, Schroeren-Boersch B, Gastmeier P, Schwab F. Surveillance of antibiotic use and resistance in intensive care units (SARI). Dtsch Arztebl Int. 2017, 114:858-65. 10.3238\/arztebl.2017.0858","journal-title":"Dtsch Arztebl Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-017-0251-8","article-title":"Intensive care antibiotic consumption and resistance patterns: a cross-correlation analysis","volume":"16","author":"Baditoiu L","year":"2017","unstructured":"Baditoiu L, Axente C, Lungeanu D, et al.. Intensive care antibiotic consumption and resistance patterns: a cross-correlation analysis. Ann Clin Microbiol Antimicrob. 2017, 16:71. 10.1186\/s12941-017-0251-8","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70017-3","article-title":"Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme","volume":"8","author":"M\u00f6lstad S","year":"2008","unstructured":"M\u00f6lstad S, Erntell M, Hanberger H, et al.. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis. 2008, 8:125-32. 10.1016\/S1473-3099(08)70017-3","journal-title":"Lancet Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001315","article-title":"Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index","volume":"4","author":"Klein EY","year":"2019","unstructured":"Klein EY, Tseng KK, Pant S, Laxminarayan R. Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index. BMJ Glob Health. 2019, 4:e001315. 10.1136\/bmjgh-2018-001315","journal-title":"BMJ Glob Health"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-016-0136-2","article-title":"Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey","volume":"15","author":"Baran I","year":"2016","unstructured":"Baran I, Aksu N. Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey. Ann Clin Microbiol Antimicrob. 2016, 15:20. 10.1186\/s12941-016-0136-2","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11131946","article-title":"Antimicrobial resistance: a growing serious threat for global public health","volume":"11","author":"Salam MA","year":"2023","unstructured":"Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, Alqumber MA. Antimicrobial resistance: a growing serious threat for global public health. Healthcare (Basel). 2023, 11:1946. 10.3390\/healthcare11131946","journal-title":"Healthcare (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112937","article-title":"Extended-spectrum \u03b2-lactamases (ESBL): challenges and opportunities","volume":"11","author":"Husna A","year":"2023","unstructured":"Husna A, Rahman MM, Badruzzaman AT, et al.. Extended-spectrum \u03b2-lactamases (ESBL): challenges and opportunities. Biomedicines. 2023, 11:2937. 10.3390\/biomedicines11112937","journal-title":"Biomedicines"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102381","article-title":"Combating Gram-negative infections: the role of antimicrobial peptides and nanotechnology in overcoming antibiotic resistance","volume":"35","author":"Carnero Canales CS","year":"2025","unstructured":"Carnero Canales CS, Marquez Cazorla JI, Marquez Cazorla RM, S\u00e1bio RM, Santos HA, Pavan FR. Combating Gram-negative infections: the role of antimicrobial peptides and nanotechnology in overcoming antibiotic resistance. Mater Today Bio. 2025, 35:102381. 10.1016\/j.mtbio.2025.102381","journal-title":"Mater Today Bio"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13081854","article-title":"Genomic epidemiology of ESBL- and carbapenemase-producing Enterobacterales in a Spanish hospital: exploring the clinical-environmental interface","volume":"13","author":"Mart\u00ednez-\u00c1lvarez SA","year":"2025","unstructured":"Mart\u00ednez-\u00c1lvarez SA, Asencio-Egea M\u00c1, Huertas-Vaquero M, Cardona-Cabrera T, Zarazaga M, H\u00f6fle U, Torres C. Genomic epidemiology of ESBL- and carbapenemase-producing Enterobacterales in a Spanish hospital: exploring the clinical-environmental interface. Microorganisms. 2025, 13:1854. 10.3390\/microorganisms13081854","journal-title":"Microorganisms"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-micro-041522-102707","article-title":"From Petri dishes to patients to populations: scales and evolutionary mechanisms driving antibiotic resistance","volume":"78","author":"Souque C","year":"2024","unstructured":"Souque C, Gonz\u00e1lez Ojeda I, Baym M. From Petri dishes to patients to populations: scales and evolutionary mechanisms driving antibiotic resistance. Annu Rev Microbiol. 2024, 78:361-82. 10.1146\/annurev-micro-041522-102707","journal-title":"Annu Rev Microbiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2015.47.2.98","article-title":"Spread of efflux pump overexpressing-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa using an efflux pump inhibitor","volume":"47","author":"Adabi M","year":"2015","unstructured":"Adabi M, Talebi-Taher M, Arbabi L, et al.. Spread of efflux pump overexpressing-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa using an efflux pump inhibitor. Infect Chemother. 2015, 47:98-104. 10.3947\/ic.2015.47.2.98","journal-title":"Infect Chemother"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202408.0736.v1","article-title":"Impact of the COVID-19 pandemic on inpatient antibiotic and antifungal drug prescribing volumes in Germany [PREPRINT]","author":"Kern WV","year":"2024","unstructured":"Kern WV, Steib-Bauert M, Baumann J, et al.. Impact of the COVID-19 pandemic on inpatient antibiotic and antifungal drug prescribing volumes in Germany [PREPRINT]. Preprints.org. 2024, 10.20944\/preprints202408.0736.v1","journal-title":"Preprints.org"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2411919121","article-title":"Global trends in antibiotic consumption during 2016-2023 and future projections through 2030","volume":"121","author":"Klein EY","year":"2024","unstructured":"Klein EY, Impalli I, Poleon S, et al.. Global trends in antibiotic consumption during 2016-2023 and future projections through 2030. Proc Natl Acad Sci U S A. 2024, 121:e2411919121. 10.1073\/pnas.2411919121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-020-00796-5","article-title":"Organization of antibiotic stewardship in Europe: the way to go","volume":"171","author":"Kern WV","year":"2021","unstructured":"Kern WV. Organization of antibiotic stewardship in Europe: the way to go. Wien Med Wochenschr. 2021, 171:4-8. 10.1007\/s10354-020-00796-5","journal-title":"Wien Med Wochenschr"},{"key":"ref24","article-title":"","author":"EUCAST: Clinical breakpoint tables","year":"2018","unstructured":"EUCAST. Clinical breakpoint tables: NethMap 2019: Consumption of Antimicrobial Agents and Antimicrobial Resistance Among Medically Important Bacteria In the Netherlands. Dutch Working Party on Antibiotic Policy (SWAB), Netherlands; 2018. https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2019-0038.pdf."},{"key":"ref25","article-title":"NethMap 2019: Consumption of Antimicrobial Agents and Antimicrobial Resistance Among Medically Important Bacteria In the Netherlands","author":"Kretzschmar ME","year":"2018","unstructured":"Kretzschmar ME, Lebret E, van Oers JA, Polder JJ, Sanders EA, Timmermans DR. RIVM Strategic Programme 2016 Annual Report Keynotes - RIVM Report 2018-0033 (Document in Dutch). National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport, Bilthoven, Netherlands; 2018. https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2018-0033.pdf."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-017-2683-4","article-title":"Antimicrobial stewardship: a qualitative study of the development of national guidelines for antibiotic use in hospitals","volume":"17","author":"Feiring E","year":"2017","unstructured":"Feiring E, Walter AB. Antimicrobial stewardship: a qualitative study of the development of national guidelines for antibiotic use in hospitals. BMC Health Serv Res. 2017, 17:747. 10.1186\/s12913-017-2683-4","journal-title":"BMC Health Serv Res"},{"key":"ref27","article-title":"A European One Health Action Plan against antimicrobial resistance (AMR). Luxembourg: Publications Office of","year":"2017","unstructured":"A European One Health Action Plan Against Antimicrobial Resistance (AMR). Publications Office of the European Union, Luxembourg; 2017. https.\/\/health.ec.europa.eu\/system\/files\/2020-01\/amr_2017_action-plan_0.pdf."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.10.009","article-title":"Predictors for treatment outcomes among patients with drug-susceptible tuberculosis in the Netherlands: a retrospective cohort study","volume":"25","author":"Pradipta IS","year":"2019","unstructured":"Pradipta IS, Van't Boveneind-Vrubleuskaya N, Akkerman OW, Alffenaar JW, Hak E. Predictors for treatment outcomes among patients with drug-susceptible tuberculosis in the Netherlands: a retrospective cohort study. Clin Microbiol Infect. 2019, 25:761.e1-7. 10.1016\/j.cmi.2018.10.009","journal-title":"Clin Microbiol Infect"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14070727","article-title":"The changing landscape of antibiotic treatment: reevaluating treatment length in the age of new agents","volume":"14","author":"Serapide F","year":"2025","unstructured":"Serapide F, Rotundo S, Gallelli L, et al.. The changing landscape of antibiotic treatment: reevaluating treatment length in the age of new agents. Antibiotics (Basel). 2025, 14:727. 10.3390\/antibiotics14070727","journal-title":"Antibiotics (Basel)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2018.01.002","article-title":"Are antimicrobial stewardship programs effective strategies for preventing antibiotic resistance? A systematic review","volume":"46","author":"Bertollo LG","year":"2018","unstructured":"Bertollo LG, Lutkemeyer DS, Levin AS. Are antimicrobial stewardship programs effective strategies for preventing antibiotic resistance? A systematic review. Am J Infect Control. 2018, 46:824-36. 10.1016\/j.ajic.2018.01.002","journal-title":"Am J Infect Control"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taac022","article-title":"European hospitals as source of multidrug-resistant bacteria: analysis of travellers screened in Finland after hospitalization abroad","volume":"29","author":"Kajova M","year":"2022","unstructured":"Kajova M, Khawaja T, Kantele A. European hospitals as source of multidrug-resistant bacteria: analysis of travellers screened in Finland after hospitalization abroad. J Travel Med. 2022, 29:022. 10.1093\/jtm\/taac022","journal-title":"J Travel Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-020-00751-4","article-title":"The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: results of a five-years pre-post analysis","volume":"9","author":"Al-Omari A","year":"2020","unstructured":"Al-Omari A, Al Mutair A, Alhumaid S, et al.. The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: results of a five-years pre-post analysis. Antimicrob Resist Infect Control. 2020, 9:95. 10.1186\/s13756-020-00751-4","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1177\/00185787251341739","article-title":"Vancomycin-induced DRESS syndrome: a systematic review of case reports","author":"Bhumireddy SK","year":"2025","unstructured":"Bhumireddy SK, Gudla SS, Vadaga AK, Nandula MS. Vancomycin-induced DRESS syndrome: a systematic review of case reports. Hosp Pharm. 2025, 00185787251341739. 10.1177\/00185787251341739","journal-title":"Hosp Pharm"},{"key":"ref34","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial consumption in the EU\/EEA (ESAC-Net) - annual epidemiological report for 2022. (2023). Accessed: January 28, 2026: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/surveillance-antimicrobial-consumption-europe-2022."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/459819-antibiotic-consumption-and-gram-negative-resistance-dynamics-in-the-icu-a-five-year-autoregressive-integrated-moving-average-arima-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:31:23Z","timestamp":1769765483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/459819-antibiotic-consumption-and-gram-negative-resistance-dynamics-in-the-icu-a-five-year-autoregressive-integrated-moving-average-arima-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.102615","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,30]]}}}